Urological research unit - Rigshospitalet

🧬 #BRCA 1/2 & #ProstateCancer: Our study finds 8x higher risk in men with BRCA1/2 than general population! 🔹 Low PSA thresholds > early detection 🔹 High Bx rates 🔹 Higher than expected rec risk despite low grade Dx @andreasroder1 @UrologicalRunit bit.ly/3WBbddu

Significant reduction in PCa-mortality for men with newly diagnosed metastatic disease with Tx intensification on national scale in 🇩🇰. However, still many fragile old men who only get mono therapy. Kudos @HeinStroomberg @signebenzon @THelgstrand ejcancer.com/article/S0959-…

We are grateful to be part of this consortium ⁦@KariStefans⁩ ⁦@SisseOstrowski⁩. Congrats to all involved and looking forward to more studies. Stay tuned for some focused on prostate cancer! ⁦@andreasroder1⁩ ⁦⁦@UrologicalRunit⁩ nature.com/articles/s4158…

Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population by @HeinStroomberg et al Full article: buff.ly/3TRTLAc #UroSoMe #MedTwitter #EUO #PCa #ProstateCancer

Outcomes of iPCa in Denmark 36% w GG1 on TURP have MRi/Bx within 5 years 15-year PCM: 8.4% GG1 on TURP, no cancer on follow up Bx = low PCM, GG2 on follow up Bx = high PCM. @LeniRiccardo @andreasroder1 @VickersBiostats @Albert0Briganti @JUrology auajournals.org/doi/10.1097/JU…

The protocol of our non-inferiority randomized TUMT-PAE-1 trial is published now. The purpose of the trial is to investigate if PAE is a non-inferior to TUMT in reducing IPSS for patients with BPH @andreasroder1 @MikkelFode @HeinStroomberg rdcu.be/dTef4

#DanProst study -Incidental #PCa mortality can be high (also for #GG1) -Likely due to unsampled PZ #GG2+ -Negative followup #Bx = low #PCSM THM: further assess #iPCa pts, how? @HeinStroomberg @VickersBiostats @andreasroder1 @Albert0Briganti @JUrology pubmed.ncbi.nlm.nih.gov/39083481/

We are proud to have contributed to the Radicals study and happy to share these publications: doi.org/10.1016/j.anno… doi.org/10.1016/S0140-… doi.org/10.1016/S0140-… Thanks to all the patients, nurses and MDs that contributed. @karinaklovgaard @andreasroder1 @PCaParker

Latest article from our brilliant student @juliadagnaesh. In this article she looked at surgical complications following renal transplantation and found short term complications in 60% of the patients. doi.org/10.1097/TXD.00… @andreasroder1 @GKristensen01 @HeinStroomberg

Our PhD student Milla Ortved presented her exciting trial comparing open vs. robotic kidney transplantation surgery at the #EAU24 in Paris. You did so well! And we are all looking forward to seeing your results coming up 💪

Back at the hospital after a very good #EAU24 with presentations, meetings and team building. We will be back next year.

Yesterday, @Rigshospitalet professor @andreasroder1 participated together with professor @heinvanpoppel in a interesting debate on #prostatecancer screening at @EAUNurses part of the conference. #EAU24

@petrasvarc @andreasroder1 @HeinStroomberg @Rigshospitalet

Final results of the DEXPAE study: doi.org/10.1007/s00270… The trial was stopped due to clinical futility but we would like to thank everyone and especially the patients involved. Conclusion: Twenty-four milligrams of Dexa is safe but does not reduce PES following PAE.

Fantastic day with Jeff Karnes @MayoUrology visiting @UrologicalRunit. The beginning of something bigger.

DR’s dokumentarserie "Med livet i hænderne" er tilbage med en tredje sæson, hvor seerne igen inviteres indenfor på Rigshospitalet. Første afsnit af den nye sæson har premiere på DR1 og DRTV, onsdag den 28. februar: bit.ly/42Oa04m #dkmedier

It has been years since we started this project, but now it is finally published in @TheLancetOncol💪Follow the link, if you would like to know more about second primary cancer in Danish cancer survivors. @cancer_dk @UrologicalRunit @CASTLE_research authors.elsevier.com/c/1iBK25EIIgLq…

We had a great meeting at #DUS. Many members of our unit presented parts of their work and chaired sessions! Always a pleasure, and we will be back in Horsens next year!

If the initial link does not work, here is an alternative. authors.elsevier.com/sd/article/S25…

The debate about changing the nomenclature of grade group 1 #prostatecancer is limited by the lack of contemporary nationwide data. Our group has now published long-term outcomes of men with a biopsy gg1 diagnosis in #Denmark. @EurUrolOncol doi.org/10.1016/j.euo.…